All News

Nakia Eldridge, PharmD, MPH, senior manager of health care quality, safety, and information at US Pharmacopeia (USP), and Lindsey Clawson, MBA, USP’s lead of COVID-19 vaccine strategy, discuss the latest updates in USP’s COVID-19 Vaccine Handling Toolkit.

FDA to evaluate luspatercept-aamt (Reblozyl) for the treatment of anemia in adults with non–transfusion dependent β-thalassemia.

Study shows that team-based medicine helps highlight the role of the pharmacist, improving outcomes.

The implementation allowed pharmacists to use online technology in anticoagulation clinics, which increased referrals and led to more accessibility, study results show.

The investigators compared blood test results from a total of 186 paramedics, some of whom received their second dose less than 4 weeks after receiving the first, whereas others received second doses after 6 to 7 weeks.

Myfembree controls heavy menstrual bleeding due to uterine fibroids in premenopausal women.

Elderberry has been used in alternative medicine as a possibly effective aid in treating constipation and other conditions.

Medicine often conflates the social construct of race with biology and fails to address the health-related consequences of systemic racism, according to the presenters.

Pharmacists can advise patients on treatments to find relief from these common winter ailments.

The workload in pharmacies may not be proportionate to census or patient load due to variations in case mix index.

Pharmacy leaders can be equipped to make effective decisions to support a successful work experience, regardless of work setting.

Involving students in advanced pharmacy practice experience rotations resulted in a greater overall impact.

Regular vaccine workflow re-education helps promote standard workflows and prevent vaccine errors.

Study results show that during a 1-year period, more than 15 patient care areas underwent rapid changes.

Pharmacy leaders and organizations should continue to advocate for the expansion of responsibilities granted by the 2020 PREP Act, according to the report.

FDA approves rituximab (Rituxan) plus chemotherapy for pediatric patients with previously untreated, advanced stage, CD20-positive diffuse large B-cell lymphoma, Burkitt lymphoma, Burkitt-like lymphoma, or mature B-cell acute leukemia.

Environmental conditions and air pollution affect health by causing injuries and fatalities, exacerbating respiratory and cardiovascular diseases, and spreading infectious diseases.

Pharmacy utilization, patterns of utilization among hypothesized treatments for COVID-19, and medication utilization patterns were all impacted by the pandemic.

Sotrovimab demonstrated ongoing activity against all tested COVID-19 variants of concern and interest, as defined by the World Health Organization.

Studies support the use of a COVID-19 vaccine booster dose to increase protection among immunocompromised individuals.

These materials are present in some angiotensin II receptor blockers used to treat heart failure and high blood pressure, and they have the potential to cause cancer.

Payton Nyquvest, CEO and founder of Numinus, discussed the laboratory development and regulatory side of psychedelic research.

Multiple GBS vaccine candidates are in development, but none are available despite development efforts spanning multiple decades.

Ibrutinib in combination with venetoclax shows promise in patients with previously untreated chronic lymphocytic leukemia.

Tukol helps loosen mucus and thin bronchial secretions to drain bronchial tubes.

Lotemax treats post-operative inflammation and pain following ocular surgery.

Febrile seizures occur in young, healthy children with normal development.